Guljit started her career with international business, strategic alliances including joint ventures and domestic marketing of pharmaceuticals, polymers with leading corporates – Ranbaxy, Reliance where she has managed profit cost centres as Vice President.
Thereafter she has been developing biotechnology initiatives over the last two decades as Director - Corporate Affairs for Monsanto with the first regulatory approval of ag-biotech Bt Cotton. As Sr VP Jubilant Organosys Ltd. handling Strategic Business Development and Corporate Communication and was a founder member of Jubilant Biosys. Since 2005 till 2014 has been responsible for setting up and scaling the operations of leading 4 global Clinical Research organisations in India namely Kendle ;i3 Research (earlier part of United Health Group) & INC Research which have now merged as Syneos , the second largest CRO ; followed by Research Pharmaceutical Services ( now part of PRA ) .
Founded Bioinnovat a Professional Knowledge Resource organisation on drug development, regulatory, compliance services, staffing and real world clinical outcomes for lifecycle management.
By academic training she is an Economics (Hons.) graduate from Lady Shri Ram College Delhi University, and MBA from Jamnalal Bajaj Institute (full time), Mumbai University. She is a Post Graduate in international marketing from IIFT Delhi and PhD. fellow from University of Pune.
At ABLE has been the nodal industry convenor for drafting of Guidelines for Similar Biologics 2016 and responsible for INNONATION, an aggregator platform identifying innovation in life sciences and health care founded or led by Indians for showcasing to PE, venture funds and investors globally.